Skip to main content

Table 1 Baseline characteristics of study participants

From: Evaluating the utility of early laboratory monitoring of antiretroviral-induced haematological and hepatic toxicity in HIV-infected persons in Cameroon

Characteristics Number (%) Characteristics Number (%)
Gender   Absolute leucocyte count (/μl)  
Female 105 (68.2)   
Male 49 (31.8) <4000 36 (27.1)
Total 154 (100) ≥4000 97 (72.9)
   Total 133 (100)
Age group (years)   Absolute platelet count (/μl)  
<30 19 (12.5)   
30-49 93 (61.2) <150000 19 (13.9)
≥50 40 (26.3) ≥150000 118 (86.1)
Total 152 (100) Total 137 (100)
Marital status   Fasting blood sugar (mg/dl)  
Single 47 (32.2)   
Married 73 (50.0) <126 130 (94.2)
Divorced 4 (2.7) ≥126 8 (5.8)
Widowed 22 (15.1) Total 138 (100)
Total 146 (100)   
Education level   NRTI-based regimen  
None 8 (7.8) AZT-based 79 (53.4)
Primary 33 (32.4) D4T-based 2 (1.3)
Secondary 57 (55.9) ABC-based 1 (0.7)
Higher 4 (3.9) TDF-based 66 (44.6)
Total 102 (100) Total 148 (100)
Alcohol use   NNRTI-based regimen  
No 73 (47.4)   
Yes 81 (52.6) NVP-based 88 (59.5)
Total 154 (100) EFV-based 60 (40.5)
   Total 148 (100)
Smoking   Other medications  
No 135 (87.7) Tuberculosis 5 (3.25)
Yes 19 (12.3) Haematinics 76 (49)
Total 154 (100) Cotrimoxazole 133 (86.4)
   Fluconazole 7 (4.5)
   Traditional medicines 1 (0.7)
Pregnancy   CD4 count (cells/μl)  
No 144 (93.5) <350 134 (93.1)
Yes 10 (6.5) ≥350 10 (6.9)
Total 154 (100) Total 144 (100)
ITN use   ALAT (U/L)  
No 94 (61.0) <45 136 (94.4)
Yes 60 (39.0) ≥45 8 (5.6)
Total 154 (100) Total 144 (100)
WHO clinical stage   ASAT (U/L)  
I 26 (19.0) <42 132 (91.7)
II 21 (15.3) ≥42 12 (8.3)
III 83 (60.6) Total 144 (100)
IV 7 (5.1)   
Total 137 (100)   
Weight (kg)   Haemoglobin (g/dl)  
<60 62 (43.7) <10 47 (32.4)
≥60 80 (56.3) ≥10 98 (67.6)
Total 142 (100) Total 145 (100)
  1. ALAT = alanine aminotransferase, ASAT = aspartate aminotransferase, ITN = insecticide treated nets, NRTI = nucleotide reverse transcriptase inhibitor, NNRTI = non-nucleotide reverse transcriptase inhibitor, ABC = abacavir, D4T = stavudine, AZT = zidovudine, TDF = tenofovir, EFV = efavirenz, NVP = nevirapine, WHO = World Health Organisation.